ETHYL 4-(13-CHLORO-4-AZATRICYCLO[9.4.0.0(3,8)]PENTADECA-1(11),3(8),4,6,12,14-HEXAEN-2-YLIDENE)PIPERIDINE-1-CARBOXYLATE | 20641 | SYRUP;ORAL | 1MG/ML

ethyl 4-{13-chloro-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene}piperidine-1-carboxylate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

55 API Suppliers, 25 USDMF, 11 CEP/COS, 6 JDMF, 13 EU WC, 17 KDMF, 17 NDC API, 27 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

33 Intermediates Suppliers

33 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

237 FDF Dossiers, 58 FDA Orange Book, 69 Europe, 12 Canada, 5 Australia, 41 South Africa, 52 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET, EXTENDED RELEASE;ORAL - 5MG;120MG, TABLET, EXTENDED RELEASE;ORAL - 10MG;240MG, SYRUP;ORAL - 1MG/ML, TABLET, ORALLY DISINTEGRATING;ORAL - 10MG, CAPSULE;ORAL - 10MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Rochem International Inc, 22 SPI Pharma, 2 Seqens, 17 DKSH, 1 Pharm-RX Chemical, 9 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 16 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 28 BASF, 1 Bioplus Life Sciences, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 6 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 32 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 10 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 43 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

111 Fillers, Diluents & Binders, 58 Coating Systems & Additives, 46 Direct Compression, 39 Thickeners and Stabilizers, 34 Taste Masking, 32 Controlled & Modified Release, 32 Disintegrants & Superdisintegrants, 30 Granulation, 28 Solubilizers, 26 Lubricants & Glidants, 25 Film Formers & Plasticizers, 23 Chewable & Orodispersible Aids, 22 Parenteral, 22 Co-Processed Excipients, 18 Topical, 9 Empty Capsules, 8 Emulsifying Agents, 8 API Stability Enhancers, 5 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

56 Finished Drug Prices

56 Finished Drug Prices

MARKET PLACE

43 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 4 USP, 26 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20641 / DOSAGE - SYRUP;ORAL - 1MG/ML

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
LORATADINE(UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN)	LORATADINE	5mg in 5

Inactive Ingredients

Ingredient Name	Major Pharmaceuticals, Inc	Pharmaceutical Associates, Inc.	Preferred Pharmaceuticals, Inc.	QUALITY CHOICE (Chain Drug Marketing Association)	TARGET Corporation	Major Pharmaceuticals	Meijer Distribution Inc	Strategic Sourcing Services LLC	Health Mart	Kroger Company	Taro Pharmaceuticals Industries, Ltd.	Bayer HealthCare LLC.	Famar Montreal Inc	NuCare Pharmaceuticals,Inc.	Preferred Pharmaceuticals Inc.	Preferred Plus (Kinray)
anhydrous citric acid(XF417D3PSL)
BUTYLATED HYDROXYANISOLE(REK4960K2U)
citric acid monohydrate(2968PHW8QP)
EDETATE DISODIUM(7FLD91C86K)
glycerin(PDC6A3C0OX)
MALTITOL(D65DG142WK)
phosphoric acid(E4GA8884NN)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
polyethylene glycols(3WJQ0SDW1A)
POLYSORBATE 80(6OZP39ZG8H)
propylene glycol(6DC9Q167V3)
SODIUM BENZOATE(OJ245FE5EU)
sodium metabisulfite(4VON5FNS3C)
SODIUM PHOSPHATE, MONOBASIC(3980JIH2SW)
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE(5QWK665956)
sorbitol(506T60A25R)
SUCRALOSE(96K6UQ3ZD4)
sucrose(C151H8M554)
water(059QF0KO0R)

Drug Product Composition: ETHYL 4-(13-CHLORO-4-AZATRICYCLO[9.4.0.0(3,8)]PENTADECA-1(11),3(8),4,6,12,14-HEXAEN-2-YLIDENE)PIPERIDINE-1-CARBOXYLATE